Showing 1 - 20 results of 888 for search '(( decrease at disease decreases processes ) OR ( decrease that decrease vivo efficacy ))*', query time: 1.01s Refine Results
2
Published 2023
... underlying chemoresistance, suggesting that its pharmacological inhibition may increase platinum efficacy...
Access document (1)
Access document (2)
Article
3
Published 2000
...We have shown that tissue-type plasminogen activator (tPA) and plasma kallikrein share a common...
Access document
Article
4
...We have shown that tissue-type plasminogen activator (tPA) and plasma kallikrein share a common...
Access document (1)
Access document (2)
Article
5
Published 2019
... to change in inflammatory diseases like myocardial infarction, stroke and implicated in psychiatric...
Access document
Article
6
Published 2011
...Desferrioxamine (DFO) is a potent iron chelator that is also known to modulate inflammation and act...
Access document
Article
7
Published 2021
...Candida albicans is a pathogen equipped with a variety of commensal and virulence traits that help...
Access document (1)
Access document (2)
Article
10
Subjects: ...L-arginine/in vivo efficacy...
Access document
Article
12
Published 2021
... evaluations about efficacy and toxicity of curcumin nanoparticles (Cur-NPs) in in vivo models of breast cancer...
Access document (1)
Access document (2)
Article
13
Published 2019
...% decrease in paw thickness at 200 mg/kg. Hence results suggested that Ribes alpestre possess antiarthritic...
Access document
Article
19
Published 2023
...Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by motor and non...
Access document
Master thesis
Export CSV Export RIS